These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28314516)

  • 1. Impact of an intrahospital mobile thrombolysis team on 3-month clinical outcomes in patients benefiting from intravenous thrombolysis for acute ischemic stroke.
    Hebant B; Triquenot-Bagan A; Guegan-Massardier E; Ozkul-Wermester O; Grangeon L; Maltête D
    Rev Neurol (Paris); 2017 Mar; 173(3):152-158. PubMed ID: 28314516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-hospital delays to stroke thrombolysis: Out of hours versus regular hours and reduction in treatment times through the creation of a 24/7 mobile thrombolysis team.
    Hebant B; Triquenot-Bagan A; Guegan-Massardier E; Ozkul-Wermester O; Maltête D
    J Neurol Sci; 2018 Sep; 392():46-50. PubMed ID: 30097154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening.
    Sablot D; Gaillard N; Colas C; Smadja P; Gely C; Dutray A; Bonnec JM; Jurici S; Farouil G; Ferraro-Allou A; Jantac M; Allou T; Pujol C; Olivier N; Laverdure A; Fadat B; Mas J; Dumitrana A; Garcia Y; Touzani H; Perucho P; Moulin T; Richard C; Heroum C; Bouly S; Sagnes-Raffy C; Heve D
    Rev Neurol (Paris); 2017; 173(1-2):47-54. PubMed ID: 28131535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the implementation of a 24-hr stroke thrombolysis emergency treatment for patients with acute ischaemic stroke.
    Zhao J; Li X; Liang Y; Zhao L; Zhang X; Liu Y
    J Clin Nurs; 2018 May; 27(9-10):2161-2167. PubMed ID: 29345016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry.
    Tsivgoulis G; Katsanos AH; Kadlecová P; Czlonkowska A; Kobayashi A; Brozman M; Švigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Krespi Y; Karapanayiotides T; Giannopoulos S; Mikulik R
    Eur J Neurol; 2017 Dec; 24(12):1493-1498. PubMed ID: 28888075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative Interventions Reduce Time-to-Thrombolysis for Acute Ischemic Stroke in a Public Safety Net Hospital.
    Threlkeld ZD; Kozak B; McCoy D; Cole S; Martin C; Singh V
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1500-1505. PubMed ID: 28396187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phased changes in strategies can reduce delay of intravenous thrombolysis administration to 15 min.
    Itabashi R; Shigehatake Y; Yazawa Y; Endo K; Saito T; Fukuma K; Furui E; Mori E
    J Neurol Sci; 2019 Aug; 403():59-64. PubMed ID: 31226551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal sustainability of guideline based door-to-needle times for intravenous thrombolysis for acute ischemic stroke.
    Raina A; Trivedi M; Kate M; Kumar L; Erat Sreedharan S; Sylaja PN
    J Clin Neurosci; 2020 Apr; 74():164-167. PubMed ID: 32094070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.
    Muengtaweepongsa S; Dharmasaroja P; Kummark U
    J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):42-6. PubMed ID: 22225863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous thrombolysis for acute ischemic stroke. A four years’ experience in a Chilean public hospital].
    Soto V Á; Morales I G; Grandjean B M; Pollak W D; Del Castillo C C; García F P; Von Johnn A A; Riquelme G A
    Rev Med Chil; 2017 Apr; 145(4):468-475. PubMed ID: 28748994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delays in door-to-needle time for acute ischemic stroke in the emergency department: A comprehensive stroke center experience.
    Mowla A; Doyle J; Lail NS; Rajabzadeh-Oghaz H; Deline C; Shirani P; Ching M; Crumlish A; Steck DA; Janicke D; Levy EI; Sawyer RN
    J Neurol Sci; 2017 May; 376():102-105. PubMed ID: 28431590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous thrombolysis in patients aged more than 80 years in the three rural hospitals in southeast Poland: an observational study.
    Sobolewski P; Brola W; Stoiński J; Szczuchniak W; Fudala M; Hatalska-Żerebiec R; Sledzińska-Dźwigał M
    Geriatr Gerontol Int; 2014 Jul; 14(3):689-94. PubMed ID: 23992393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.